Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia - Contacts and Locations

Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00158223

Contacts


Contact: Michelle Bergmann	631-761-2717

Locations


United States, New York
	The Mount Sinai Hospital	Recruiting
	New York, New York, United States, 10029
	Contact: Mariangela Cavagna 212-659-9223 mariangela.cavagna@mssm.edu
	Principal Investigator: Joseph I. Friedman, MD
	Pilgrim Psychiatric Center	Recruiting
	W. Brentwood, New York, United States, 11717
	Contact: Michelle Bergman 631-761-2717 PGMDMIL@omh.state.ny.us
	Principal Investigator: Joseph I. Friedman, MD
	Manhattan Psychiatric Center	Recruiting
	New York, New York, United States, 10035
	Contact: Frances Alcantara 646-672-6173 Marcffa@omh.state.ny.us
	Principal Investigator: Jean-Pierre I. Lindenmayer, MD

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators


Principal Investigator:	Joseph I. Friedman, MD	Mount Sinai School of Medicine